Cutler Group’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-3,500
| Closed | -$48K | – | 4959 |
|
|
2019
Q3 | $48K | Sell |
3,500
-2,000
| -36% | -$200K | ﹤0.01% | 1573 |
|
|
2019
Q2 | $54K | Buy |
5,500
+3,800
| +224% | +$410K | 0.01% | 1499 |
|
|
2019
Q1 | $1K | Sell |
1,700
-2,800
| -62% | -$206K | ﹤0.01% | 3906 |
|
|
2018
Q4 | $34K | Buy |
4,500
+3,700
| +463% | +$160K | ﹤0.01% | 1729 |
|
|
2018
Q3 | $11K | Sell |
800
-1,400
| -64% | -$95.7K | ﹤0.01% | 2628 |
|
|
2018
Q2 | $4K | Sell |
2,200
-4,900
| -69% | -$378K | ﹤0.01% | 3316 |
|
|
2018
Q1 | $12K | Sell |
7,100
-30,100
| -81% | -$1.74M | ﹤0.01% | 2695 |
|
|
2017
Q4 | $433K | Sell |
37,200
-18,200
| -33% | -$1.31M | 0.02% | 607 |
|
|
2017
Q3 | $132K | Buy |
55,400
+40,500
| +272% | +$3.08M | ﹤0.01% | 1452 |
|
|
2017
Q2 | $79K | Sell |
14,900
-2,900
| -16% | -$162K | ﹤0.01% | 2068 |
|
|
2017
Q1 | $85K | Buy |
17,800
+10,300
| +137% | +$612K | ﹤0.01% | 1895 |
|
|
2016
Q4 | $31K | Sell |
7,500
-9,400
| -56% | -$504K | ﹤0.01% | 3040 |
|
|
2016
Q3 | $43K | Buy |
16,900
+13,000
| +333% | +$749K | ﹤0.01% | 2621 |
|
|
2016
Q2 | $16K | Buy |
3,900
+100
| +3% | +$4.27K | ﹤0.01% | 3636 |
|
|
2016
Q1 | $42K | Sell |
3,800
-30,000
| -89% | -$946K | ﹤0.01% | 2527 |
|
|
2015
Q4 | $247K | Buy |
+33,800
| New | +$1.77M | 0.01% | 1020 |
|
Cutler Group's ONCE Position: Q3 2019 in Review
Cutler Group sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q3 2019, closing a stake of 5,100 shares — an estimated $511K sold.
Cutler Group first reported a position in ONCE in Q4 2015 and held it in 11 quarters. The position peaked at $1.86M in Q4 2017. 184 funds tracked by Wall St. Rank hold ONCE as of Q3 2019.
- Cutler Group reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
- Cutler Group sold 5,100 Spark Therapeutics, Inc. Common Stock shares in Q3 2019, an estimated $511K.
- Cutler Group first reported a position in Spark Therapeutics, Inc. Common Stock in Q4 2015 and held it in 11 quarters.
- Cutler Group's Spark Therapeutics, Inc. Common Stock position peaked at $1.86M in Q4 2017.
- 184 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q3 2019.
Based on Cutler Group's 13F filing for Q3 2019, filed 28 Oct 2019.